![2020_Pictor Logo_RGB 2020_Pictor Logo_RGB](https://pictordx.com/wp-content/uploads/elementor/thumbs/2020_Pictor-Logo_RGB-qj3kineny4qj5u4wqfsyq8xufw39g8typb95x6s68i.png)
![](https://pictordx.com/wp-content/uploads/2022/11/logo_PictHealth-768x111.png)
![](https://pictordx.com/wp-content/uploads/2022/11/Gradient_PictHealth.png)
PictArray™ SARS-CoV-2 Semi-Quantitative ELISA Antibody Test
Everyone’s antibody response is different. That’s why our test is too.
COVID-19 is an infectious disease caused by the SARS-CoV-2 virus.
After vaccination or infection, immune response is individual and variable. Variation in responses have been linked to age, sex, ethnicity in addition to previous SARS-CoV-2 infection status. Importantly, the clinically vulnerable are reported to generate lower levels of antibodies compared with healthier people following vaccination or infection.
PictArray™ SARS-CoV-2 Semi-Quantitative ELISA Antibody test separately detects antibodies from vaccines and viral infection.
The PictArray™ SARS-CoV-2 Antibody Test is now available for healthcare providers and patients who would like to gain the following insights:
The presence of IgG antibodies towards:
-
- Spike Protein (SP) indicates prior vaccination; and
- Nucleocapsid Protein (NP) indicates prior infection
The PictArray™ Testing Advantage:
-
- Ability to detect multiple biomarkers in one test well i.e. Spike protein (SP) and Nucleocapsid protein (NP).
- Differentiates those who have antibodies from vaccination from those who have antibodies from a previous infection.
- Clinically proven sensitivity and specificity in one test sees faster testing and improved accuracy and reliability.
![](https://pictordx.com/wp-content/uploads/2022/11/diagram_vaccine-768x562.jpg)
Whether patients have an immune response to vaccination or if their immunity has diminished over time.
![](https://pictordx.com/wp-content/uploads/2022/11/diagram_covid_virus-768x562.png)
Whether or not patients have been previously infected with SARS-Cov-2 and have developed antibodies against the virus
![](https://pictordx.com/wp-content/uploads/2022/11/diagram_people-768x562.jpg)
Identify at risk patients who have failed to mount an effective antibody response despite having been previously vaccinated or infected.
The PictHealth™ SARS-CoV-2 IgG ELISA Kit is available now.
Please contact orders@pictordx.com for further information.
Contact Us